TRXB Trex Bio, Inc.
Fundamentals / CIK 0002139097 / USDTrex Bio, Inc. reported $88.75M in total assets through September 30, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRXB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Sep 30, 2026
-
Operating Income FY 2026-- Operating profit
-
Net Income FY 2026-- GAAP bottom line
-
Diluted EPS FY 2026-- Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$78.15M Total debt: $2.81M
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Research & Development | $11.43M | -- | -- | $6.97M | -- | -- |
| Total Operating Expenses | $13.92M | -- | -- | $8.71M | -- | -- |
| Operating Income | -$13.92M | -- | -- | -$8.71M | -- | -- |
| Interest Income | $768K | -- | -- | $853K | -- | -- |
| Income Before Tax | -$13.15M | -- | -- | -$7.86M | -- | -- |
| Income Tax Expense | $88K | -- | -- | $0 | -- | -- |
| Net Income | -$13.24M | -$13.09M | -$16.22M | -$7.86M | -$8.33M | -$9.39M |
| Basic EPS | -$10.06 | -- | -- | -$7.58 | -- | -- |
| Diluted EPS | -$10.06 | -- | -- | -$7.58 | -- | -- |
| Basic Shares Outstanding | 1.3M | -- | -- | 1.0M | -- | -- |
| Diluted Shares Outstanding | 1.3M | -- | -- | 1.0M | -- | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2025-12-31 |
|---|---|---|
| Cash & Cash Equivalents | $16.81M | $15.19M |
| Short-Term Investments | $61.34M | $52.53M |
| Cash & Short-Term Investments | $78.20M | $67.72M |
| Total Current Assets | $79.85M | $71.43M |
| Property, Plant & Equipment, Net | $826K | $482K |
| Other Non-Current Assets | $5.35M | $538K |
| Total Non-Current Assets | $8.91M | $1.70M |
| Total Assets | $88.75M | $73.13M |
| Accounts Payable | $1.72M | $371K |
| Total Current Liabilities | $10.53M | $4.99M |
| Other Non-Current Liabilities | $103K | $72K |
| Total Non-Current Liabilities | $3.50M | $1.24M |
| Total Liabilities | $14.03M | $6.24M |
| Total Debt (incl. Leases) | $2.81M | $717K |
| Common Stock | $0 | $0 |
| Retained Earnings | -$136.8M | -$94.26M |
| Accumulated Other Comp. Income | -$151K | $17K |
| Total Stockholders' Equity | -$134.1M | -$92.12M |
| Total Equity | -$134.1M | -$92.12M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Net Income | -$13.24M | -$13.09M | -$16.22M | -$7.86M | -$8.33M | -$9.39M |
| Stock-Based Compensation | $178K | -- | -- | $129K | -- | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Current Ratio | 7.58x | -- | -- | -- | -- | -- |
| Quick Ratio | 7.43x | -- | -- | -- | -- | -- |